Stock Price
54.96
Daily Change
-4.28%
Yearly
-16.56%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Takeda 3,092.00 -44.00 -1.40% -17.44%
Eisai 7,070.00 -85.00 -1.19% -10.36%
Acadia Pharmaceuticals 18.84 0.05 0.27% -66.75%
Alnylam Pharmaceuticals 180.74 -7.79 -4.13% 39.13%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 203.47 2.38 1.18% -8.36%
Arena Pharmaceuticals 54.96 -2.46 -4.28% -16.56%
Biogen 236.11 -6.79 -2.80% -1.69%
BioMarin Pharmaceutical 87.40 -0.18 -0.21% 11.05%
Cara Therapeutics 12.58 -0.22 -1.72% -14.25%
Cytokinetics 38.77 -0.26 -0.67% 130.77%
DBV Technologies 3.07 0.07 2.33% 25.31%
Esperion Therapeutics 8.68 0.90 11.57% -69.35%
Gilead Sciences 70.73 0.46 0.65% 16.58%
GlaxoSmithKline 1,525.00 14.20 0.94% 11.31%
Halozyme Therapeutics 33.28 -0.57 -1.68% -14.88%
Intercept Pharmaceuticals 16.43 -0.67 -3.92% -53.73%
Incyte Corp 70.60 2.22 3.25% -16.49%
Ionis Pharmaceuticals 29.05 -0.71 -2.39% -43.18%
Intra Cellular Therapies 40.93 -1.52 -3.58% 73.14%
Ligand Pharmaceuticals 155.29 -1.56 -0.99% 84.06%
PTC Therapeutics 36.89 -1.17 -3.07% -41.04%
Regeneron Pharmaceuticals 655.79 12.44 1.93% 27.08%
Regulus Therapeutics 0.39 -0.02 -4.87% -37.95%
Spectrum Pharmaceuticals 1.58 -0.11 -6.51% -66.45%
Sarepta Therapeutics 79.86 0.24 0.30% -43.31%
TG Therapeutics 23.36 -0.62 -2.59% -20.38%
TherapeuticsMD 0.57 -0.01 -1.54% -57.19%
United Therapeutics 194.00 0.36 0.19% 46.26%
Vanda Pharmaceuticals 16.87 0.32 1.93% 38.17%
Vertex Pharmaceuticals 190.15 6.56 3.57% -16.51%
Vivus 0.12 0 0% -95.76%
Zogenix 11.40 -0.30 -2.56% -46.80%
Ziopharm Oncology 1.29 -0.06 -4.44% -53.93%

Indexes Price Day Year
US2000 2242 -3.96 -0.18% 23.20%
NASDAQ 15783 291.18 1.88% 29.38%

Arena Pharmaceuticals
Arena Pharmaceuticals, Inc. is a biopharmaceutical company focused on delivering transformational medicines with optimized pharmacology and pharmacokinetics to patients globally. The Company's clinical programs include Etrasimod, which is an oral, selective sphingosine 1-phosphate (S1P), receptor modulator, designed to provide systemic and local cell modulation by targeting S1P receptor subtypes one, four and five. Olorinab, an orally available, potent, peripherally acting, selective, full agonist of the CB2 receptor, is an internally discovered investigational drug candidate. APD418 is an adrenergic receptor (AdrR) antagonist and cardiac myotrope designed to regulate myofilament calcium sensitivity in order to improve contractility without inducing the adverse events associated with available inotropes. Temanogrel is a peripherally acting and selective 5HT2a inverse agonist designed to inhibit serotonin (5-HT) mediated amplification of platelet aggregation and vasoconstriction.